Adolescents’ gender, n (%) |
Male |
60 (80.0) |
|
Female |
15 (20.0) |
|
Adolescents’ age, mean (SD) |
14.8 (1.8) |
|
Time since first symptoms (years), mean (SD) |
8.1 (3.5) |
|
Time since diagnosis of TS (years), mean (SD) |
4.0 (3.0) |
|
Treatment reported for tics, n
(%)
|
54 (72.0) |
|
Neuroleptics/Antipsychotics |
51 (68.0) |
|
Others |
8 (10.7) |
|
Other treatment reported,
n
(%)
|
19 (25.3) |
|
Antidepressants |
13 (17.3) |
|
Anxiolytics |
6 (8.0) |
|
Attention-deficit/hyperactivity disorders |
4 (5.3) |
|
Sleep disorders |
3 (4.0) |
|
Actual symptoms reported by mothers, n (%) |
ADHD |
41 (54.7) |
|
COD |
16 (21.3) |
|
Learning disabilities |
34 (45.3) |
|
Anxiety |
51 (68.0) |
|
Depression |
16 (21.3) |
|
Sleeping disorder |
23 (30.7) |
|
Medical monitoring for TS reported by mothers, n (%) |
Psychiatrist or child psychiatrist |
34 (45.3) |
|
Psychologist |
28 (37.3) |
|
YGTSS scores, mean (SD) |
Motor tics |
13.2 (4.8) |
|
Vocal tics |
9.4 (6.1) |
|
Overall impairment |
11.3 (13.7) |
|
Total |
33.9 (20.0) |
|
CY-BOCS scores, mean (SD) |
Obsessions |
2.4 (4.6) |
|
Compulsions |
3.6 (5.1) |
|
Total |
6.0 (9.0) |
|
MOVES scores, mean (SD) |
Motor tics |
5.4 (2.8) |
|
Vocal tics |
2.9 (3.0) |
|
Obsessions |
2.1 (2.5) |
|
Compulsions |
3.0 (2.4) |
|
Other associated symptoms |
1.2 (2.0) |
|
Total |
14.2 (9.3) |
|
CBCL scores reported by parents |
Total problems, mean (SD) |
53.6 (25.0) |
44.1 (23.1) |
Borderline or clinical range, n (%) |
41 (57.7) |
25 (41.7) |
Internalizing symptoms, mean (SD) |
17.6 (8.9) |
14.8 (8.9) |
Borderline or clinical range, n (%) |
45 (61.6) |
32 (52.5) |
Externalizing symptoms, mean (SD) |
14.3 (9.0) |
11.0 (6.9) |
Borderline or clinical range, n (%) |
33 (44.0) |
21 (33.3) |
Parents’ age (years), mean (SD) |
44.1 (4.7) |
47.1 (6.2) |
Parents’ marital status, n (%) |
Single |
1 (1.3) |
1 (1.6) |
Married/living with partner |
64 (85.3) |
58 (92.1) |
Separated/divorced |
9 (12.0) |
4 (6.3) |
Widowed |
1 (1.3) |
0 |
Parents’ level of education, n (%) |
Lower than or equal to high school |
44 (58.7) |
37 (58.7) |
Superior to high school |
31 (41.3) |
25 (40.3) |
Family size, mean (SD) |
4.0 (0.9) |
3.9 (1.2) |
Health problems, n (%) |
23 (30.7) |
20 (31.7) |
Medical treatment,
n
(%)
|
29 (39.2) |
19 (30.2) |
Antidepressants |
10 (13.3) |
5 (7.9) |
Anxiolytics |
6 (8.0) |
1 (1.6) |
Hypnotics |
2 (2.7) |
0 |
Others |
19 (25.3) |
14 (22.2) |
SF-36 scores, mean (SD) |
Physical functioning |
87.2 (16.6) |
95.2 (6.2) |
Role physical |
78.1 (32.3) |
82.4 (26.6) |
Bodily pain |
74.5 (25.3) |
82.5 (17.4) |
Vitality |
46.2 (18.7) |
61.1 (14.9) |
Mental health |
56.0 (19.7) |
66.8 (19.1) |
Role emotional |
68.0 (40.7) |
83.0 (30.1) |
Social functioning |
70.1 (24.6) |
79.2 (22.2) |
General health |
65.7 (15.7) |
70.1 (15.5) |
WHOQOL-BREF scores, mean (SD) |
Physical health |
70.5 (18.0) |
79.1 (12.7) |
Psychological health |
60.3 (17.8) |
62.9 (14.9) |
Social relationships |
65.4 (18.7) |
60.0 (24.6) |
Environment |
68.2 (16.0) |
69.5 (15.9) |
Anxiety |
HADS-A score, mean (SD) |
8.4 (4.1) |
6.8 (3.7) |
Possible or probable clinical case, n (%) |
42 (56.0) |
20 (31.7) |
Depression |
HADS-D score, mean (SD) |
5.7 (3.7) |
4.8 (4.2) |
Possible or probable clinical case, n (%) |
22 (29.3) |
14 (22.2) |